117 related articles for article (PubMed ID: 38000702)
1. Inhibiting LCN2 can suppress the development of NSCLC by promoting ferroptosis.
Pan Z; Li B; Lu P; Rong G; Wang X
Gene; 2024 Feb; 894():148026. PubMed ID: 38000702
[TBL] [Abstract][Full Text] [Related]
2. WTAP Mediates NUPR1 Regulation of LCN2 Through m
Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.
Valashedi MR; Roushandeh AM; Tomita K; Kuwahara Y; Pourmohammadi-Bejarpasi Z; Kozani PS; Sato T; Roudkenar MH
Life Sci; 2022 Sep; 304():120704. PubMed ID: 35714703
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis
in Lung Adenocarcinoma Cells].
Liu L; Guan X; Zhao Y; Wang X; Yin C; Liu Q; Li H
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):813-821. PubMed ID: 38061883
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
[TBL] [Abstract][Full Text] [Related]
6. CircSCN8A suppresses malignant progression and induces ferroptosis in non-small cell lung cancer by regulating miR-1290/ACSL4 axis.
Liu B; Ma H; Liu X; Xing W
Cell Cycle; 2023 Apr; 22(7):758-776. PubMed ID: 36482742
[TBL] [Abstract][Full Text] [Related]
7. Exploring the ferroptosis-related gene lipocalin 2 as a potential biomarker for sepsis-induced acute respiratory distress syndrome based on machine learning.
Zhan J; Chen J; Deng L; Lu Y; Luo L
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167101. PubMed ID: 38423372
[TBL] [Abstract][Full Text] [Related]
8. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
9. Identification of Lipocalin 2 as a Potential Ferroptosis-related Gene in Ulcerative Colitis.
Deng L; He S; Li Y; Ding R; Li X; Guo N; Luo L
Inflamm Bowel Dis; 2023 Sep; 29(9):1446-1457. PubMed ID: 37000707
[TBL] [Abstract][Full Text] [Related]
10. ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through inhibition of apoptosis and ferroptosis.
Wang T; Wang K; Zhu X; Chen N
BMC Mol Cell Biol; 2023 Mar; 24(1):14. PubMed ID: 37003979
[TBL] [Abstract][Full Text] [Related]
11. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells.
Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D
Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
13. The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC).
Cui X; Liu C; Dong P; Liu C; Bai Y
BMC Pulm Med; 2023 May; 23(1):162. PubMed ID: 37165402
[TBL] [Abstract][Full Text] [Related]
14. STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma.
Lai Y; Zhang Z; Li J; Li W; Huang Z; Zhang C; Li X; Zhao J
Biochem Biophys Res Commun; 2019 Nov; 519(4):659-666. PubMed ID: 31542233
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin-2 silencing suppresses inflammation and oxidative stress of acute respiratory distress syndrome by ferroptosis via inhibition of MAPK/ERK pathway in neonatal mice.
Wang X; Zhang C; Zou N; Chen Q; Wang C; Zhou X; Luo L; Qi H; Li J; Liu Z; Yi J; Li J; Liu W
Bioengineered; 2022 Jan; 13(1):508-520. PubMed ID: 34969358
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia.
Wang D; Li X; Jiao D; Cai Y; Qian L; Shen Y; Lu Y; Zhou Y; Fu B; Sun R; Tian Z; Zheng X; Wei H
J Hematol Oncol; 2023 Mar; 16(1):30. PubMed ID: 36973755
[TBL] [Abstract][Full Text] [Related]
18. Silencing LCN2 enhances RSL3-induced ferroptosis in T cell acute lymphoblastic leukemia.
Tian C; Zheng M; Lan X; Liu L; Ye Z; Li C
Gene; 2023 Aug; 879():147597. PubMed ID: 37390872
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of m
Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
[TBL] [Abstract][Full Text] [Related]
20. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
